Sample of Q2 2024 Pharma Drug Sales KPIs
Here's a short summary of drug sales for 4 pharmaceutical companies from earnings reports in Q2 '24. Two of the firms reported this morning (July 30th) so the data is fresh. Included in this small sample are Johnson & Johnson (ticker: JNJ), Pfizer (ticker: PFE), Abbvie (ticker: ABBV) and Merck (ticker: MRK). Using our Excel Add in and our Disclosures query tools, we are able to extract these segments in a flash. A few noteworthy things. Drugs that formed a significant portion of revenue in Q2 2024 are Merck Keytruda (45%) and Gardasil (15%) J&J Stelara (13%) and Darzalex (13%) AbbVie Humira (16%) Skyrizi (16%) Pfizer Elliquis (14%) Time Series of Revenues by Firm / Drug below